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Abstract
Background: Otitis media is one of the most common infections of early childhood. Surfactant
protein A functions as part of the innate immune response, which plays an important role in
preventing infections early in life. This prospective study utilized a candidate gene approach to
evaluate the association between polymorphisms in loci encoding SP-A and risk of otitis media
during the first year of life among a cohort of infants at risk for developing asthma.
Methods: Between September 1996 and December 1998, women were invited to participate if
they had at least one other child with physician-diagnosed asthma. Each mother was given a
standardized questionnaire within 4 months of her infant's birth. Infant respiratory symptoms were
collected during quarterly telephone interviews at 6, 9 and 12 months of age. Genotyping was done
on 355 infants for whom whole blood and complete otitis media data were available.
Results: Polymorphisms at codons 19, 62, and 133 in SP-A1, and 223 in SP-A2 were associated
with race/ethnicity. In logistic regression models incorporating estimates of uncertainty in
haplotype assignment, the 6A4/1A5haplotype was protective for otitis media among white infants
in our study population (OR 0.23; 95% CI 0.07,0.73).
Conclusion: These results indicate that polymorphisms within SP-A loci may be associated with
otitis media in white infants. Larger confirmatory studies in all ethnic groups are warranted.
Background
Otitis media is one of the most common infections of
early childhood: 60%-80% of children will have at least
one episode during their first year of life [1,2]. Rates of
early-onset (before 6 months of age) and recurrent otitis
media are increasing in the United States [3,4]. Recurrent
otitis media may increase a child's risk for hearing loss
and delays in speech development [1,5].
Acute otitis media is an infectious disease resulting from
complex interactions between microbes, the environ-
ment, and the host immune response. The majority of epi-
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sodes are thought to be bacterial, but acute otitis media is
most often associated with, or preceded by, a viral respira-
tory infection [6,7]. Epidemiologic studies have consist-
ently highlighted the importance of daycare attendance
and the number of siblings as predictors of acute otitis
media [6,7]. Genetic factors play an important role in oti-
tis media susceptibility. Monozygotic twins have higher
concordance in otitis media rates than dizygotic twins,
and estimates of heritability range from 0.45–0.74 [8-10].
While studies have provided strong evidence of a genetic
predisposition to otitis media, only a few studies have
identified specific genes related to otitis media risk
[11,12].
The innate immune response may be critical for otitis
media susceptibility in early life before the acquisition of
specific immunity. Surfactant protein A (SP-A) is the most
abundant surfactant protein in the lung, and is an impor-
tant component of the innate immune system [13]. SP-A
is a member of the collectin protein family; these proteins
recognize carbohydrates on the surface of pathogens via
the carbohydrate recognition domain [14]. As a pattern
recognition receptor, SP-A functions in the first line of
defense in the absence of specific antimicrobial antibod-
ies. SP-A knockout mice show delayed clearance of otitis
media associated pathogens Haemophilus influenzae and
respiratory syncitial virus (RSV) [15]. The gene locus for
SP-A is in chromosome 10q21 through q24 and has two
functional and highly homologous SP-A genes (SP-A1
and SP-A2) [16-18].
SP-A has been detected in the Eustachian tube [19] and
may play a role in the pathogenesis of otitis media [20].
Recurrent otitis media has previously been linked to the
6A4/1A5 haplotype in SP-A [11]. This study took place in
Finland, and the distribution of SP-A haplotypes in the
Finnish population has been shown to differ from fre-
quencies found within the United States [21]. Among a
prospective cohort of infants at risk for developing
asthma, we used a candidate gene approach to determine
whether polymorphisms within the SP-A1 and SP-A2
genes were associated with any otitis media during the
first year of life.
Methods
Cohort
Data used in this report were obtained from infants
enrolled in a longitudinal cohort to study the impact of
environmental exposures on asthma development and
morbidity. Between September 1996 and December
1998, women delivering babies in six hospitals were
invited to participate if they had at least one other child at
home younger than 12 years of age with physician-diag-
nosed asthma. Because of the asthmatic sibling, these
infants were considered at risk for this disease. A full
description of the methods is provided elsewhere [22-24].
Our Human Investigations Committee as well as institu-
tional review boards at each participating hospital
reviewed and approved the study.
Of the initial 1,002 infants enrolled, data were available
on otitis media during the first year of life for 889.
Between the third and fifth year of participation, a second
visit was made to the home at which time an effort was
made to collect a blood sample from the cohort subjects.
The analyses in this report include a convenience sample
of 355 infants for whom whole blood and complete quar-
terly otitis media data were available.
Data collection
Trained research assistants described the study to the
infant's mother, obtained written informed consent, and
administered standardized questionnaires to study partic-
ipants during home interviews within 4 months of the
infant's birth. We collected household demographic data
such as maternal race and ethnicity, education, and
number of children. We also collected detailed informa-
tion regarding infant care such as use of daycare, any
breastfeeding during the first year of life, and whether the
infant was exposed to environmental tobacco smoke
(ETS) in the home. Mothers were asked to report on their
history of allergies or physician-diagnosed asthma. Infant
respiratory symptoms were collected during quarterly tel-
ephone interviews at 6, 9 and 12 months of age. During
these telephone interviews, we asked the mother to report
her infant's respiratory symptoms and doctor or clinic vis-
its (month and year of visit, reason for visit, and mother's
report of the diagnosis). When the infant reached one year
of age, each mother completed an extensive phone ques-
tionnaire covering her infant's health status during the
previous year.
Definitions of otitis media
Otitis media was ascertained during each quarterly survey
by mother's report of an episode of clinician-diagnosed
otitis media with the month and year of diagnosis. Addi-
tional physician diagnoses of otitis media occurring in the
same month or next consecutive month were counted as
a single episode.
Genotyping of SP-A genes
DNA from whole blood samples was extracted using the
QIAamp DNA blood minikit (Qiagen) according to the
manufacturer's instructions. Genotyping for the single
nucleotide polymorphisms (SNPs) at aa19, aa50, aa62,
aa133, and aa219 in SP-A1 and aa9, aa91, aa223 in SP-A2
were done using a sequence specific primer-PCR method-
ology described by Pantelidis et al.[25]. This method
involves high stringency PCR amplification using allele-
specific primers designed with the final 3' end nucleotideBMC Medical Genetics 2006, 7:68 http://www.biomedcentral.com/1471-2350/7/68
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complementary to the nucleotide variants within a partic-
ular SNP locus. In our hands, this method did not give
reproducible results for the CT polymorphism at aa140
within SP-A2. To detect polymorphisms in SP-A2 at
aa140, we used PCR based cRFLP as described by
DiAngelo et al. [26].
Data analysis
Unadjusted associations between otitis media episodes
and selected study characteristics, SNPs, and individual
SP-A1 or -A2 alleles were initially evaluated by χ2 tests.
Observed SNP frequencies were tested for Hardy-Wein-
berg equilibrium by χ2 analysis. Allele haplotypes for SP-
A1 and for SP-A2 were examined for linkage disequilib-
rium and haplotype frequencies were estimated using
PROC HAPLOTYPE in the SAS/Genetics module of SAS
version 9.1 (Cary, NC). Logistic regression was used to
model the association between SP-A1 and SP-A2 haplo-
types and otitis media. Note that specific haplotypes can
only be inferred since each individual has two chromo-
somes, and the methods of genotyping provide only the
two bases at each site without a chromosomal assign-
ment. For example, homozygous SNPs result in one and
only one haplotype assignment. In the presence of heter-
ozygous SNPs, the allele haplotype could be one of sev-
eral, each occurring with a probability based on observed
SNP frequencies. Therefore, we made an effort to estimate
the effect of uncertainty in haplotype assignment on
model variability. We used the set of potential haplotypes
(PROC HAPLOTYPE) and a regression calibration tech-
nique similar to that described by Carroll et al. [27] to cre-
ate 100 separate data sets by randomly assigning a
haplotype for a particular subject based on the probability
of each of the possible haplotypes given for that subject.
Next, 100 separate logistic regression models with coeffi-
cient and variance estimates for the ith model of bi and
, respectively, were fit for each haplotype of interest.
The estimate of the association ( ) between otitis media
and each particular haplotype was calculated as the mean
of the 100 logistic regressions. The variability of the esti-
mate was calculated as
var ( ) = mean ( ) + var (bis)
where mean ( ) is defined as the mean of the 100 logis-
tic regression variances and var (bis) is defined as the var-
iance of the 100 logistic regression b coefficients.
Results
Participant characteristics
The majority of the 355 infants in our study experienced
otitis media during their first year. Thirty-eight percent of
the infants experienced only one episode of otitis media,
24% experienced two, and 10% had three or more epi-
sodes during their first year of life (Table 1). Male infants
were more likely to experience otitis media during their
first year of life: 78% of males experienced otitis media
compared to 67% of female infants (P = 0.02). Black
infants tended to have less otitis media than white or His-
panic infants during their first year of life. For example,
58% of black infants experienced otitis media compared
to 77% of white infants and 73% of Hispanic infants (P =
0.06). We did not find significant associations between
maternal education, maternal allergies, maternal asthma,
daycare before six months of age, breastfeeding, exposure
to ETS in the home, or season of birth and otitis media
during the first year of life.
There were socioeconomic differences between the group
from the study cohort who chose to participate in the
blood draw (355 out of 889 [40%]) and those who did
not (n = 554): whole blood samples were obtained from
more white infants (64% vs. 57%) and fewer Hispanic
infants (18% vs. 26%) (P = 0.04), more of the mothers in
the blood draw group had college degrees (39% vs. 31%,
P = 0.03) and chose to breastfeed their infants (68% vs.
60%, P = 0.02). The rates of otitis media between the two
blood draw groups did not differ: 28% compared to 26%
for otitis media in the first 6 months; 73% vs. 71% for any
otitis media in the first year; and 10% vs. 9% for 3 or more
episodes of otitis media in the first year for the blood draw
participants vs. non-participants, respectively.
Analysis of single nucleotide polymorphisms
Table 2 contains unadjusted associations between each of
the nine candidate SNPs and otitis media for all 355
infants in our sample. Each of the individual SNPs was in
Hardy-Weinberg equilibrium in the full sample of 335
subjects and within each racial/ethnic category (P > 0.05).
Polymorphisms in SP-A1 at codon 19 were associated
with otitis media during the first year of life. Infants with
an alanine (CT) at codon 19 were also more likely to have
a greater number of otitis media episodes during their first
year of life. The percentage of infants with an alanine at
codon 19 and 0, 1, and 2 or more episodes of otitis media
during their first year were 10%, 49%, and 41% respec-
tively. In contrast, the percentage of infants with valine
(homozygote TT) at codon 19 and 0, 1, and 2 or more epi-
sodes of otitis media during their first year were 31%,
36%, and 33% respectively (P = 0.01).
We did not find associations between polymorphisms
within any of the SNPs and gender, maternal education,
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maternal allergies, maternal asthma, daycare before six
months, exposure to ETS, or season of birth. Codons 19,
62, and 133 in SP-A1, and 223 in SP-A2 were associated
with race/ethnicity (Figure 1). Given the association of
otitis media with both race/ethnicity and specific poly-
morphisms within our study population, we restricted our
haplotype analyses to the ethnic group with the largest
number of subjects (226 white infants).
The unadjusted relationship between polymorphisms in
each of the SNPs and any episode of otitis media was
examined in logistic regression models in the white
infants. White infants having an alanine (CT) at SP-A1
codon 19 were more than 3.8 times more likely (95% CI
1.3, 11.2) than those with a valine (TT) to have otitis
media during their first year of life.
Allele and haplotype analyses
We designated the SP-A1 and SP-A2 alleles by 6An and
1Am respectively as has been previously described [21,26].
The associated nomenclature as well as the nucleotide and
amino acid changes in the major SP-A1 and SP-A2 alleles
are given in Table 3. The five SNPs in SP-A1 were in link-
age disequilibrium. The most common SP-A1 allele hap-
lotypes among the white infants in our study population
were 6A2, 6A3, 6A4, and 6A in decreasing order of fre-
quency. The four SNPs in SP-A2 were also in linkage dise-
quilibrium (P < 0.0001). 1A0 was the most common SP-
Table 1: Unadjusted associations between personal characteristics and otitis media episodesa for 355 infants at risk for developing 
asthma. (CT and MA, 1998 – 2000)
Otitis Media Episodes
012 3 +
C h a r a c t e r i s t i c n  ( % ) %%% %
All subjects N (%) 355 97 (27.3) 137 (38.6) 87 (24.5) 34 (9.6)
Gender
Male 171 (48.2) 21.6 42.7 24.6 11.1
Female 184 (51.8) 32.6 34.8 24.5 8.2
Ethnicity
White 226 (63.7) 23.4 38.0 28.8 9.7
Black 48 (13.5) 41.7 37.5 14.6 6.2
Hispanic 62 (17.5) 27.4 41.9 22.6 8.1
Other 19 (5.4) 36.8 36.8 5.3 21.0
Maternal education
< HS 38 (10.7) 29.0 36.8 29.0 5.3
Some college 179 (50.4) 29.0 39.7 20.1 11.2
College degree 138 (38.9) 24.6 37.7 29.0 8.7
Maternal allergies
No 146 (41.1) 30.8 39.7 24.0 5.5
Yes 209 (58.9) 24.9 37.8 24.9 12.4
Maternal asthma
No 246 (69.3) 30.1 38.2 22.0 9.8
Yes 109 (30.7) 21.1 39.4 30.3 9.2
Daycare before 6 mo
No 279 (78.6) 29.0 39.4 23.3 8.2
Yes 76 (21.4) 21.0 35.5 29.0 14.5
Breast feeding
No 113 (31.8) 27.4 40.7 22.1 9.7
Yes 242 (68.2) 27.3 37.6 25.6 9.5
ETS
No 304 (86.6) 26.0 38.5 26.3 9.2
Yes 47 (13.4) 34.0 40.4 14.9 10.6
Season of birth
Winter 75 (21.1) 28.0 37.3 26.7 8.0
Spring 101 (28.4) 25.7 41.6 24.8 7.9
Summer 97 (27.3) 26.8 39.2 27.8 6.2
Fall 82 (23.1) 29.3 35.4 18.3 17.1
aOtitis media determined by mother's report. More than one episode reported in a month or in the next consecutive month counted as a single 
episode.BMC Medical Genetics 2006, 7:68 http://www.biomedcentral.com/1471-2350/7/68
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A2 allele among the white infants in our study followed
by 1A1, 1A2, 1A, 1A5, 1A6, and 1A3. All others combined
made up 4% of the SP-A2 alleles.
We examined associations between any otitis media dur-
ing the first year of life and specific allele haplotypes in SP-
A1 and SP-A2 (Table 3). The 6A4 allele of SP-A1 was pro-
tective for otitis media in white infants (OR 0.34; 95% CI
0.15, 0.79). The 1A5 allele in SP-A2 was underrepresented
among white infants with otitis media (OR 0.38; 95% CI
0.14, 1.05). White infants with the 1A allele in SP-A2 were
over 3 times more likely to have otitis media during the
first year of life (OR 3.03; 95% CI 0.88, 10.39), but with
wide confidence intervals that included unity.
SP-A1 and SP-A2 alleles are in close proximity and are
known to be in strong linkage disequilibrium [28,29].
Within our population of white infants, the SP-A1 and SP-
A2 allele haplotypes were also in linkage disequilibrium
(P < 0.0001). Since the alleles at these two loci cosegregate
as one unit, we examined the distribution of SP-A1 and
SP-A2 alleles together. Unadjusted relationships between
the SP-A haplotypes and any episode of otitis media are
shown in Table 4. We did not adjust for other known oti-
tis media risk factors (e.g. daycare, breastfeeding) because
these were not associated with polymorphisms in SP-A.
Consistent with our allele analysis, white infants with the
6A4/1A5 haplotype experienced decreased risk for otitis
media during their first year of life (OR 0.23; 95% CI
0.07,0.73).
Discussion
We found that specific SNPs, alleles, and haplotypes of
SP-A were associated with otitis media risk among a
cohort of infants at risk for asthma. The 6A4 allele haplo-
type was protective for otitis media in white infants during
their first year. Correspondingly, white infants with the
6A4/1A5 haplotype experienced a 76% decreased risk for
otitis media during the first year of life.
These data are in contrast to a Finnish study of the associ-
ation between SP-A polymorphisms and otitis media [11].
That study reported that the 6A4/1A5 haplotype was over-
represented among children with both acute otitis media
before 6 months of age and recurrent otitis media. Under
our definition of otitis media, which did not distinguish
between acute otitis media and otitis media with effusion,
otitis media before 6 months was highly correlated with
season of birth. Among infants born in the summer or fall,
one-third or more (33% and 42%, respectively) had otitis
media before 6 months of age compared to less than one-
quarter (23% and 18%, respectively) of the infants born
in winter or spring (χ2, P = 0.002). Otitis media has been
shown to undergo seasonal variation in parallel with res-
piratory virus infections [30]: rates are highest in the fall
and winter months. We did not have enough power (i.e.,
too few subjects to stratify analysis by season of birth) to
detect associations with otitis media before 6 months and
specific SP-A haplotypes. In addition, by definition, our
episode count for the first year of life was conservative. We
identified a small number of white infants (n = 25) with
3 or more otitis media episodes during their first year,
which perhaps accounts for our finding no association
between recurrent otitis media and SP-A haplotypes. The
population in the Finnish study was different from ours:
Table 2: Unadjusted associations between SNPs from surfactant 
protein A alleles (SP-A1, SP-A2) and otitis media (OM) episodes 
before 12 months of age for 355 infants at risk for developing 
asthma. (CT and MA, 1998 – 2000)
OM Episodes
SNP n (%) %
All subjects N (%) 355 258 (72.7)
SP-A1a
aa 19b
CC 1 (0.3)
CT 56 (15.8) 89.5
TT 294 (83.8) 69.0
aa 50
CC 75 (21.2) 80.0
CG 171 (48.3) 69.0
GG 108 (30.5) 74.1
aa 62
GG 5 (1.4)
AG 88 (25.2) 74.2
AA 256 (73.4) 71.9
aa 133
GG 2 (0.6)
AG 51 (14.4) 83.0
AA 302 (85.1) 70.9
aa 219
TT 1 (0.3)
CT 46 (13.0) 68.1
CC 308 (86.8) 73.4
SP-A2a
aa 9
CC 73 (20.6) 74.0
AC 171 (48.2) 71.9
AA 111 (31.3) 73.0
aa 91
CC 6 (1.7)
CG 85 (24.2) 73.6
GG 261 (74.2) 72.4
aa 140
TT 25 (7.1) 64.0
CT 142 (40.2) 71.1
CC 186 (52.7) 75.3
aa 223
AA 18 (5.1) 77.8
AC 129 (36.3) 72.9
CC 208 (58.6) 72.1
aEach of the SNPs was in Hardy-Weinberg equilibrium (P > 0.05).
bP = 0.02, χ2-test.BMC Medical Genetics 2006, 7:68 http://www.biomedcentral.com/1471-2350/7/68
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children in the Finnish study were older (1–10 years of
age), and cases were children with recurrent otitis media
who were admitted to the hospital for adenoidectomy,
tympanostomy, or both. The controls for the Finnish
study were consecutive infants born in the hospital.
RSV infection has been strongly linked to the pathogene-
sis of acute otitis media [6] and polymorphisms in SP-A
have been linked to susceptibility to bronchiolitis caused
by this virus [31]. Lofgren et al. [31] found that 6A/1A was
protective for severe RSV infection in infants (OR 0.17;
95% CI 0.04, 0.80), and the 6A2/1A3 haplotype was asso-
ciated with increased risk of disease (OR 10.4; 95% CI 1.3,
83.2). Neither of these haplotypes was associated with oti-
tis media in our study population. Interestingly, the fre-
quency of infants with 6A4/1A5, our protective otitis
media-associated haplotype, was slightly lower among
infants with RSV infections when compared to the control
group (4% vs 7%) [31].
Our results indicate that SNPs at aa19 in the SP-A1 gene
are associated with otitis media risk. Codon 19 is located
in the N terminal domain of SP-A1. Further experiments
are needed to identify whether amino acid changes in this
region impact biological properties such as gene expres-
sion levels or interactions with pathogens. Infants with an
alanine at codon 19 were more likely to have otitis media
during their first year of life. Infants with the 6A4/1A5 hap-
lotype have a valine at codon19.
While the association of SP-A with otitis media is biolog-
ically plausible, otitis media is a multigenic, multifactorial
disease, and there are likely other susceptibility genes
involved. A genome scan mapped recurrent otitis media
Ethnic distribution of surfactant protein A (SP-A) SNPs among infants at risk for developing asthma (P-values from χ2 tests) Figure 1
Ethnic distribution of surfactant protein A (SP-A) SNPs among infants at risk for developing asthma (P-values from χ2 tests).BMC Medical Genetics 2006, 7:68 http://www.biomedcentral.com/1471-2350/7/68
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to chromosome q10 at marker D10S212 and to chromo-
some 19q at marker D19S254 [32]. SP-A is contained on
chromosome 10, but is in a separate region from
D10S212.
In our study, black infants experienced less otitis media
than white infants. The potential problems associated
with population stratification related to ethnicity have
been addressed with regard to surfactant proteins [33].
Table 4: Estimated frequency distribution of surfactant protein A (SP-A) haplotypes among infants at risk for the development of 
asthma. Unadjusted odds ratios (OR) and 95% confidence intervals (CI) from logistic regression modelsa of any episodes of otitis media 
before 12 months of age. (N = 226 white infants, CT and MA, 1998 – 2000.)
SP-A Haplotypeb Estimated Frequency Distributionc % (95% CI) Any OM Episodes OR (95% CI)
6A/1A 5.4% (3.2 – 7.2) 2.13 (0.59, 7.68)
6A2/1A0 49.0% (44.4 – 53.6) 1.10 (0.53, 2.30)
6A2/1A2 1.8% (0.6 – 2.9) 1.71 (0.20, 14.4)
6A2/1A3 1.0% (0.2 – 1.9) 0.90 (0.09, 8.83)
6A3/1A0 4.7% (2.8 – 6.6) 0.87 (0.29, 2.58)
6A3/1A1 11.3% (8.5 – 14.1) 0.70 (0.33, 2.47)
6A3/1A2 5.6% (3.6 – 7.6) 0.90 (0.33, 2.47)
6A3/1A6 1.7% (0.5 – 2.8) 0.73 (0.13, 4.01)
6A4/1A5 2.9% (1.4 – 4.4) 0.23 (0.07, 0.73)
6A4/1A6 1.8% (0.6 – 3.0) 0.46 (0.10, 2.09)
Others 14.9%
aSeparate logistic regression analyses were performed for each outcome measure and each haplotype with all other haplotypes serving as the 
reference group in each model. All model results include estimates of model variability due to ambiguity in allele haplotype assignment (see "Data 
analysis" in text).
bN = 217 infants with complete data for both SP-A1 and SP-A2 alleles.
cEstimated frequency distribution of SP-A haplotypes (mean, 95% CI) for white infants.
Table 3: Surfactant protein A (SP-A1 and SP-A2) allele haplotypesa and unadjusted odds ratios (OR) and 95% confidence intervals (CI) 
from logistic regression modelsb of any episodes of otitis media before 12 months of age. (CT and MA, 1998 – 2000)
Allele, haplotypec Nucleotide/amino acidd Estimated Frequency Distribu-
tione % (95% CI)
Any OM Episodes OR (95% CI)
SP-A1 aa 19 aa 50 aa 62 aa 133 aa 219
6A C/Ala C/Leu G G C/Arg 6.1% (4.0 – 8.3) 1.96 (0.63, 6.10)
6A2 T/Val G/Val A A C/Arg 54.0% (49.3 – 58.7) 0.95 (0.44, 2.04)
6A3 T/Val C/Leu A A C/Arg 25.6% (21.6 – 29.6) 0.85 (0.45, 1.60)
6A4 T/Val C/Leu G A T/Trp 6.2% (4.1 – 8.4) 0.34 (0.15, 0.79)
all others 8%
SP-A2 aa 9 aa 91 aa 140 aa 223
1A C/Thr C/Pro C C/Gln 8.4% (6.0 – 10.8) 3.03 (0.88, 10.39)
1A0 A/Asn G/Ala C C/Gln 54.2% (49.5 – 58.8) 1.04 (0.48, 2.25)
1A1 C/Thr G/Ala T A/Lys 13.7% (10.7 – 16.7) 0.69 (0.34, 1.39)
1A2 C/Thr G/Ala C C/Gln 10.2% (7.6 – 12.7) 0.98 (0.43, 2.22)
1A3 A/Asn G/Ala T A/Lys 1.8% (0.7 – 2.9) 0.80 (0.15, 4.35)
1A5 C/Thr C/Pro T C/Gln 4.6% (2.7 – 6.5) 0.38 (0.14, 1.05)
1A6 C/Thr G/Ala T C/Gln 3.2% (1.7 – 4.7) 0.77 (0.20, 2.92)
all others 4%
aN = 219 white infants with complete data for SP-A1 alleles and N = 222 white infants with complete data for SP-A2 alleles.
bSeparate logistic regression analyses were performed for each outcome measure and each haplotype with all other haplotypes serving as the 
reference group in each model. All model results include estimates of model variability due to ambiguity in allele haplotype assignment (see "Data 
analysis" in text).
cBy convention [ref Lofgren et al JID 2002;185:283-289], SP-A1 allele haplotypes are denoted by 6An and SP-A2 alleles by 1Am.
dCodons aa62, aa133, and aa140 are silent.
eEstimated frequency distribution of SP-A1 and SP-A2 haplotypes (mean, 95% CI) for white infants.BMC Medical Genetics 2006, 7:68 http://www.biomedcentral.com/1471-2350/7/68
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Seven ethnic groups from three races (Caucasian, Black
and Hispanic) were examined, and SP-A allele and geno-
type frequencies were shown to differ between ethnic
groups from different races. We did not have enough sub-
jects in the black (n = 47 with complete data) or Hispanic
(n = 62 with complete data) groups to examine the asso-
ciations of specific haplotypes with otitis media.
As stated previously, 60–80% of infants in the United
States experience otitis media during the first year of life.
Our finding that 73% of infants experienced otitis media
during the first year is on the high end of this range. This
may be due in part to the special nature of our population.
All of the infants in our cohort have an older sibling in the
home. Exposure to other children has been shown to be
associated to otitis media [1,2]. In contrast to other stud-
ies [1-4], we did not find a strong association between oti-
tis media and attendance in daycare outside the home.
Infants in our study experienced a greater number of otitis
media episodes, but the difference was not statistically sig-
nificant. Another study, of 806 infants from the same
cohort, identified an association between early otitis
media and attendance in daycare before six months of age
[24]. Therefore, the lack of statistical significance is likely
due to the small number of white infants (76 total)
attending daycare before six months of age.
One limitation of this study was that the cohort examined
was not specifically recruited to study otitis media. We
collected data by asking mothers whether their infants
had a clinician-diagnosed medical condition. The diag-
nostic criteria may have differed between clinicians. Fur-
thermore, mothers reported diagnosis of an ear infection
but were not asked to distinguish between acute otitis
media and otitis media with effusion. Different genetic
polymorphisms may influence different otitis media phe-
notypes. Since we were unable to distinguish between dif-
ferent types of otitis media, grouping all types together
may have diluted our findings. Since accuracy in episode
counts was dependent on maternal report, we attempted
to limit recall bias by asking mothers about their child's
medical conditions every three months. Parents have been
shown to accurately report the number of otitis media epi-
sodes (kappa = 0.94) [34]. Our study used a conservative
count of otitis media episodes: two episodes occurring
within the same month or consecutive months counted as
one episode.
The generalizability of our results may also be limited
given that our cohort contains children at risk for asthma.
Since SP-A is part of the innate immune system in the
lungs, infants in our cohort could differ in SP-A1 and SP-
A2 hapylotype distributions compared to the general pop-
ulation. Liu et al. examined SP-A1 and SP-A2 allele haplo-
type frequencies in over 300 white Americans [33]. Their
results indicate that SP-A1 allele haplotype frequencies
were 56.2% 6A2, 24.3% 6A3, 9.3% 6A, 7.6% 6A4 and 2.6%
other. Approximate allele haplotype frequencies for SP-A2
were 53% 1A0, 10.2% 1A, 14.3% 1A1, 7.6% 1A2, and
14.9% all others. With the exception of allele haplotype
6A (SP-A1), the distribution of SP-A1 and SP-A2 haplo-
types in our population (Table 3) is similar to that of
white Americans in the general population.
Strengths of this study include the prospective study
design and well characterized demographic and illness
information for the infant cohort. Adjustments for uncer-
tainty in haplotype assignment are rarely incorporated
into association studies of genetic haplotypes and disease;
instead these studies often use the most likely haplotype
assignment [35]. We utilized logistic regression models
that incorporate estimates of the effect of this uncertainty
to more accurately model the association between poly-
morphisms in SP-A and otitis media.
Conclusion
We identified polymorphisms within SP-A loci that are
associated with otitis media in white infants at risk for
asthma. These polymorphisms may play a biological role
in disease, or these polymorphisms may be in linkage dis-
equilibrium with other unmeasured markers that may be
the causal polymorphism. While we cannot definitively
state whether the polymorphisms are causative or are neu-
tral markers, the results of this study suggest a role for SP-
A in otitis media susceptibility. Further studies are needed
to replicate, in white and other ethnic groups, our obser-
vation of a relationship between otitis media in the first
year of life and polymorphisms in SP-A.
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